These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19545196)

  • 1. Risk assessment of chemical carcinogens and thresholds.
    Neumann HG
    Crit Rev Toxicol; 2009; 39(6):449-61. PubMed ID: 19545196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of thresholds on the risk assessment of carcinogens in food.
    Pratt I; Barlow S; Kleiner J; Larsen JC
    Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: example of a threshold carcinogen.
    Sweeney LM; Kirman CR; Albertini RJ; Tan YM; Clewell HJ; Filser JG; Csanády G; Pottenger LH; Banton MI; Graham CJ; Andrews LS; Papciak RJ; Gargas ML
    Crit Rev Toxicol; 2009; 39(6):462-86. PubMed ID: 19545197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of peak exposure to genotoxic carcinogens: a pragmatic approach.
    Bos PM; Baars BJ; van Raaij MT
    Toxicol Lett; 2004 Jun; 151(1):43-50. PubMed ID: 15177639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product.
    Eichenbaum G; Johnson M; Kirkland D; O'Neill P; Stellar S; Bielawne J; DeWire R; Areia D; Bryant S; Weiner S; Desai-Krieger D; Guzzie-Peck P; Evans DC; Tonelli A
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):33-42. PubMed ID: 19500632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thresholds in chemical carcinogenesis.
    Purchase IF; Auton TR
    Regul Toxicol Pharmacol; 1995 Dec; 22(3):199-205. PubMed ID: 8837843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive toxicants have a threshold of adversity.
    Piersma AH; Hernandez LG; van Benthem J; Muller JJ; van Leeuwen FX; Vermeire TG; van Raaij MT
    Crit Rev Toxicol; 2011 Jul; 41(6):545-54. PubMed ID: 21609253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.